Mucinous breast carcinoma

Breast

Volumn 11, Issue 4, 2002, Pages 359-361

  Lannigan, A K ^a   Going, J J ^b   Weiler Mithoff, E ^b   Cooke, T G ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b CANNIESBURN PLASTIC SURGERY UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; MUCIN; TAMOXIFEN;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST ADENOCARCINOMA; BREAST BIOPSY; BREAST TUMOR; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MASTECTOMY; MUCINOUS CARCINOMA; NEUTROPENIA; POSTOPERATIVE CARE; PRIORITY JOURNAL; SEPSIS; TUMOR VOLUME;

EID: 0036700720     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.2002.0417     Document Type: Article

References (17)

1. Azzopardi J G. In: Bennington J L eds. Problems in breast pathology. London: WB Saunders, 1979: 294-296.
2. Rosen P P, Lesser M L, Kinne D W. Breast carcinoma at the extremes of age: comparison of patients younger than 35 years and older than 75 years. J Surg Oncol 1985; 28: 90-96.
3. Rasmussen B B, Carsten R, Christensen I B. Prognostic factors in primary mucinous breast carcinoma. Am J Clin Pathol 1987; 87: 155-160.
4. Norris H J, Taylor H B. Prognosis of mucinous (gelatinous) carcinoma of the breast. Cancer 1965; 18: 879-881.
5. Melamed M R, Robbins G F, Foote F W. Prognostic significance of gelatinous mammary carcinoma. Cancer 1961; 14: 699.
6. Silverberg S G, Kay S, Chitale A R, Levitt S H. Colloid carcinoma of the breast. Am J Clin Pathol 1971; 55: 355-363.
7. Lesser M L, Rosen P P, Senie R T, Duthie K, Menendez-Botet, Schwartz M K. Estrogen and progesterone receptors in breast carcinoma; correlations with epidemiology and pathology. Cancer 1981; 48: 299-309.
8. Schmidt F, Hartwagner K A, Spork E B, Groell R. Medical audit after 26,711 breast imaging studies: improved rate of detection of small breast carcinomas. Cancer 1998; 83: 2516-2520.
9. Cardenosa G, Doudna C, Eklund G W. Mucinous (colloid) breast cancer: clinical and mammographic findings in 10 patients. Am J Roentgenol 1994; 162: 1077-1079.
10. Fentiman I S, Mills R R, Smith P, Ellul J P, Lampejo O. Mucoid breast carcinomas: histology and prognosis. Br J Cancer 1997; 75: 1061-1065.
11. Clayton F. Pure mucinous carcinomas of breast: morphologic features and prognostic correlates. Hum Pathol 1986; 17: 34-38.
12. Komaki K, Sakamoto G, Sugano H, Morimoto T, Monden Y. Mucinous carcinoma of the breast in Japan. A prognostic analysis based on morphologic features. Cancer 1988; 61: 989-996.
13. André S, Cunha F, Bernardo M, Sousa M, Cortez F, Soares J. Mucinous carcinoma of the breast: a pathologic study of 82 cases. J Surg Oncol 1995; 58: 162-167.
14. Toikkanen S, Kujari H. Pure and mixed mucinous carcinomas of the breast: a clinicopathologic analysis of 61 cases with long term follow-up. Human Pathol 1989; 20: 758-764.
15. Diab S G, Clark G M, Osborne C K, Libby A, Allred D C, Elledge R M. Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol 1999; 17: 1442-1448.
16. Avisar E, Khan M A, Axelrod D, Oza K. Pure mucinous carcinoma of the breast: a clinicopathologic correlation study. Ann Surg Oncol 1988; 5: 447-451.
17. Von Minckwitz G, Costa S D, Eiermann W, Blohmer J U, Tulusan A H, Jackisch C, Kaufmann M. Maximised reduction in primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel. J Clin Oncol 1999; 17: 1999.